Order Radiesse® 1.5 mL for Clinics

Radiesse® 1.5 mL is a calcium hydroxylapatite (CaHA) injectable filler supplied in a prefilled syringe for trained healthcare professionals. Licensed clinics, med spas, and aesthetic practices can order Radiesse 1.5 mL for professional facial contouring, tissue volumization, and dorsal hand correction protocols. The unit includes one 1.5 mL syringe and two sterile 27 G 1/2" needles for aseptic treatment-room use.

This presentation is intended for subdermal and deep dermal placement by qualified injectors. CaHA microspheres are suspended in a gel carrier, giving the product a cohesive handling profile for structural support and contour definition. Med Wholesale Supplies serves licensed clinics and healthcare professionals with brand-name medical products sourced through vetted distributors and verified supply channels.

Clinic Ordering, Price, and 1.5 mL Syringe Details

Current prices and quantity breaks are shown on this page, and licensed clinics can order as a guest or with an account. The 1.5 mL size is also described as 1.5 cc, because 1 mL equals 1 cc. Each unit contains one prefilled syringe with 1.5 mL of product, which helps purchasing teams plan inventory by treatment area, appointment mix, and provider preference.

Your team can use purchase history and product documentation to align restocking with clinic protocols, staff training, and anticipated procedure volume. For practices standardizing around the brand, the Radiesse brand selection can help staff review related presentations without changing the core CaHA workflow.

Radiesse is not measured in toxin-style units. Treatment planning is typically discussed in mL or syringes, with the actual amount determined by the injector’s assessment, treatment area, anatomy, and clinic protocol. Purchasing staff should avoid converting dermal filler volume into neuromodulator units, because the products are planned and documented differently.

Professional Applications and Treatment-Room Fit

Clinicians use this class of injectable filler for structural facial contouring, volumization of tissue deficits, and dorsal hand correction. Common professional workflows may include midface contouring, lower-face definition, cheek support, chin projection, jawline refinement, and correction of moderate-to-severe facial folds such as nasolabial folds. Technique, plane, injection device, and total volume remain clinical decisions for trained providers.

The Radiesse 1.5 mL syringe suits practices that want a cohesive, sculptable filler for defined contour rather than a very soft, superficial gel. Providers may use needle or cannula techniques based on anatomical plan and operator preference. Typical room workflow includes consultation documentation, marking, aseptic preparation, injection, molding when appropriate, and post-procedure assessment.

Radiesse can sit alongside hyaluronic acid fillers in a clinic inventory, because different filler classes offer different handling characteristics. Practices that provide multi-product aesthetic plans often maintain a broader Radiesse 1.5 mL with lidocaine option for protocols where an anesthetic-containing variant is preferred. Product choice should follow clinic policy, injector training, and patient-specific assessment.

How Calcium Hydroxylapatite Filler Works

Radiesse is a calcium hydroxylapatite filler. CaHA microspheres are suspended in a gel carrier that provides immediate volume and contour after placement. Over time, the microspheres can act as a scaffold that supports neocollagenesis, meaning new collagen formation in the treated tissue. This biostimulatory profile is why many clinics position CaHA fillers for structural support and longer-term skin-quality planning.

The handling profile differs from many hyaluronic acid fillers. HA gels are often selected for hydration, flexibility, and reversibility considerations, while CaHA is commonly chosen for firmer support and contour definition. A concise clinical discussion of this class is available in the Radiesse collagen biostimulation article.

CaHA filler selection should account for the treatment area, depth, tissue quality, patient history, and the injector’s experience. This product is not a substitute for surgical lifting, skin resurfacing, or neuromodulator treatment when those interventions are more appropriate. It is best integrated into a broader aesthetic plan that defines the objective for each area before product is opened.

Key Features for Professional Inventory

• Calcium hydroxylapatite microspheres suspended in a smooth gel carrier
• One prefilled syringe containing 1.5 mL of product
• Two sterile 27 G 1/2" needles included in the carton
• Single-use, sterile packaging for aseptic clinical workflows
• Manufacturer labeling with lot and expiry for traceability
• Cohesive rheology for structural placement and contour control
• Professional-use format suited to trained injectors
• SKU: 81459

The carton supports predictable unit-of-use inventory control. Staff can record lot and expiry details at receipt, store product according to manufacturer instructions, and document the device used during the procedure. Newer packaging does not include a printed instruction booklet; the instructions are provided as an e-IFU accessible by scanning the QR code.

Composition, Packaging, and Handling

This product contains CaHA microspheres suspended in a gel vehicle. The active structural component is calcium hydroxylapatite, a well-characterized bioceramic used in aesthetic medicine. Practices should consult the current manufacturer instructions for complete composition, approved use details, contraindications, warnings, and technique-specific handling information.

Each unit is supplied as a single professional-use package containing 1 x 1.5 mL prefilled syringe and 2 x 27 G 1/2" needles. The syringe and needles are intended for sterile, single-use procedures. Do not use packaging that appears damaged, opened, or inconsistent with expected manufacturer labeling, and quarantine any questionable unit according to clinic policy.

Inventory teams should store and handle the product in line with the manufacturer’s current instructions. During procurement, our logistics process supports temperature-controlled handling when required and tracked US delivery. Receipt checks should include product name, presentation, lot number, expiry date, carton condition, and internal documentation requirements before the unit is released for treatment-room use.

Safety, Contraindications, and Adverse Reactions

Radiesse should be administered only by trained professionals who understand facial and hand anatomy, injection planes, vascular risk, aseptic technique, and management of complications. Providers should screen for contraindications and risk factors using the manufacturer’s current instructions and clinic protocols. Patient history, prior filler placement, active infection, inflammatory skin conditions, bleeding risk, allergies, and planned procedures can all affect suitability.

Expected transient reactions may include irritation, tenderness, swelling, redness, bruising, firmness, itching, discoloration, or small lumps at injection sites. Providers should counsel patients on normal post-procedure observations and signs that require follow-up. More serious complications can occur with injectable fillers, including vascular compromise, tissue injury, infection, nodules, granulomatous reactions, or visual symptoms if product is inadvertently injected into or near a vessel.

Clinic teams should maintain written protocols for filler emergencies, documentation, adverse event escalation, and post-procedure communication. Product placement in high-risk areas requires appropriate training and clinical judgment. For a broader regulator-backed discussion of dermal filler risks and patient counseling points, consult the FDA’s current dermal filler safety information through its medical device safety materials.

Workflow Benefits for Aesthetic Practices

Clinics value the 1.5 mL format because it can support common bilateral contouring plans while preserving unit-level traceability. The cohesive gel can be molded after placement when clinically appropriate, helping trained injectors refine contour and transition zones. The included needles reduce basic setup friction, although providers may select alternative devices if supported by technique, labeling, and clinic standards.

Radiesse can help consolidate filler inventory for practices that treat facial volume loss, lower-face structure, and hands. It may be especially useful in clinics that prefer a defined support product alongside softer HA fillers. Clear internal protocols help staff prepare the room, verify documentation, record lot information, and support efficient turnover without reducing clinical safeguards.

Quick tip: Keep CaHA and HA filler protocols clearly separated in training materials so staff do not confuse volume planning, reversibility considerations, or emergency steps.

Radiesse 1.5 mL, Radiesse with Lidocaine, and Larger Presentations

Radiesse 1.5 mL is the non-lidocaine presentation described here. Radiesse plus 1.5 mL with lidocaine refers to a related formulation that includes lidocaine for comfort-focused protocols when the anesthetic-containing variant is appropriate. Clinics that use both should keep ordering, storage, and treatment documentation clear so staff select the correct syringe for each procedure.

Some practices also stock larger presentations for higher-volume clinic needs. The Radiesse 3 mL presentation may be useful for clinics that plan broader inventory coverage, while the 1.5 mL unit can remain practical for targeted cases and controlled restocking. Selection should follow expected procedure volume, expiry management, and injector preference.

For comparative planning across biostimulatory fillers, many teams also evaluate poly-L-lactic acid products. The Sculptra and Radiesse comparison outlines key class differences, and Sculptra 2 vials may be considered when a clinic’s protocol calls for a different collagen-stimulating approach.

Comparable Products and Adjacent Choices

Radiesse and hyaluronic acid fillers are not interchangeable by default. HA products may be preferred for certain areas, softer tissue integration, or protocols where the clinic values an HA-specific profile. CaHA may be preferred when the provider wants structural support and contouring control. The correct choice depends on indication, anatomy, tissue quality, and the injector’s treatment plan.

For a side-by-side class discussion, the Radiesse and Juvederm Voluma comparison may help staff understand why clinics often keep both filler types available. Practices that use HA volumizers can also evaluate Juvederm Voluma with lidocaine as an adjacent product for appropriate HA-based contouring protocols.

Training teams should avoid choosing a filler only by syringe size or headline indication. The practical decision includes depth, tissue movement, desired lift, reversibility considerations, adverse-event planning, and whether a biostimulatory effect is part of the clinical objective. Documenting those criteria helps purchasing staff align inventory with the procedures actually performed.

Authoritative Sources

NIH MedlinePlus dermal fillers information

Ready to order? Choose your quantity above, or call 1-800-630-9757 to talk to our customer service team.

This content is for informational purposes only and is not a substitute for professional medical advice.